Myelin News and Research

RSS

Myelin is the fatty substance that covers and protects nerves.

MRI is useful, not just in diagnosing MS, but also in the monitoring of therapies in clinical trials

Progressive changes within the brain occur earlier in multiple sclerosis than previously supposed, according to a study presented October 4, 2004, at the 129th annual meeting of the American Neurological Association.

4 Oct 2004

Important discovery that will increase the understanding of multiple sclerosis

Scientists at the University of California, Santa Barbara have made an important discovery that will increase the understanding of multiple sclerosis, a debilitating disease of the central nervous system in which the myelin sheath, an insulating membrane surrounding the nerve cells in the brain and spinal cord, start to unravel for reasons as yet unknown.

14 Sep 2004

Scientists closer to correcting an abnormal gene which causes Charcot-Marie-Tooth disease

Scientists at the University of Edinburgh are closer to correcting an abnormal gene which causes one of the crippling muscle wasting diseases known collectively as Charcot-Marie-Tooth (CMT) disease.

10 Sep 2004

Study shows that in older age, myelin insulation breaks down, resulting in a decline in the speed and efficiency of our brain

UCLA neuroscientists using a new MRI analysis technique to examine myelin sheaths that insulate the brain's wiring report that as people age, neural connections that develop last degenerate first.

12 Jul 2004

Topiramate may protect newborns from brain injury and long-term neurologic problems caused by excitotoxicity

An existing drug already approved by the FDA may protect newborns from brain injury and long-term neurologic problems caused by excitotoxicity, or over-activation of neurons, report two NIH-funded studies from Children's Hospital Boston.

14 Jun 2004

Drug commonly used for diabetes might be effective in treating multiple sclerosis

Researchers at the University of Illinois at Chicago are launching a clinical trial to determine whether a drug commonly used for diabetes might be effective in treating multiple sclerosis, an autoimmune disease that affects 350,000 Americans.

10 Jun 2004

Acne drug may help treat multiple sclerosis

Dr. Luanne Metz, an associate professor of neurosciences and physician-scientist in the Neuroscience Research Group at the University of Calgary’s Faculty of Medicine, has found that minocycline, a drug currently used to treat such conditions as acne, decreases the activity of lesions in the brains of people suffering from multiple sclerosis (MS).

2 Jun 2004

Researchers identify molecules that underlie nerve fiber degeneration in multiple sclerosis patients

Yale researchers and collaborators have identified molecules that underlie nerve fiber degeneration in patients with secondary progressive multiple sclerosis (MS), a disease that cripples nearly three million people worldwide. The new findings are the first observations in humans of molecules that contribute to degeneration of nerve fibers.

27 May 2004

Trial shows Daclizumab therapy improves multiple sclerosis outcome

A small clinical trial of patients with multiple sclerosis (MS) who did not respond to interferon alone found that adding the human antibody daclizumab improved patient outcome. Patients who received the combined therapy had a 78 percent reduction in new brain lesions and a 70 percent reduction in total lesions, along with other significant clinical improvements.

24 May 2004

Combination therapy may be useful in humans with spinal cord injury

A combination therapy using transplanted cells plus two experimental drugs significantly improves function in paralyzed rats, a new study shows. The results suggest that a similar therapy may be useful in humans with spinal cord injury.

23 May 2004

Protein that appears to play a key role in Alzheimer's disease

A protein that allows human cancer to resist multiple anticancer drugs also appears to play a key role in Alzheimer's disease, according to research conducted at Fox Chase Cancer Center. The protein, active in brain tissue, could be a target for new drugs to treat patients with Alzheimer's.

20 May 2004

Myelin News and Research

Further Reading

MRI is useful, not just in diagnosing MS, but also in the monitoring of therapies in clinical trials

Important discovery that will increase the understanding of multiple sclerosis

Scientists closer to correcting an abnormal gene which causes Charcot-Marie-Tooth disease

Study shows that in older age, myelin insulation breaks down, resulting in a decline in the speed and efficiency of our brain

Topiramate may protect newborns from brain injury and long-term neurologic problems caused by excitotoxicity

Drug commonly used for diabetes might be effective in treating multiple sclerosis

Acne drug may help treat multiple sclerosis

Researchers identify molecules that underlie nerve fiber degeneration in multiple sclerosis patients

Trial shows Daclizumab therapy improves multiple sclerosis outcome

Combination therapy may be useful in humans with spinal cord injury

Protein that appears to play a key role in Alzheimer's disease

Cholesterol-lowering drugs could treat multiple sclerosis

Teens who suffered iron deficiency as infants are likely to score lower on cognitive and motor tests

Australian study helps to better understand MS disease

Scientists get new motor neurons to migrate through the spinal cord

Clinical trial of enzyme replacement therapy for the treatment of Gaucher disease

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News